Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study

Autor: Tang-Hsiu Huang, Chin-Wei Kuo, Chian-Wei Chen, Yau-Lin Tseng, Chao-Liang Wu, Sheng-Hsiang Lin

Publikováno v: BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-13 (2021)

Abstract Background Nintedanib is effective for treating idiopathic pulmonary fibrosis (IPF), but some patients may exhibit a suboptimal response and develop on-treatment acute exacerbation (AE-IPF), hepatic injury, or mortality. It remains unclear w

Externí odkaz: https://doaj.org/article/2491455cfb9d4a70bcaa273ffdd29110

Diffuse alveolar hemorrhage secondary to plastic fume exposure: A case report

Autor: Omkar K. Choudhari, Umesh Chandra Ojha, Dipti Gothi, Sonam Spalgais, Pratap Singh, Anita Rani

Publikováno v: Monaldi Archives for Chest Disease, Vol 90, Iss 3 (2020)

A 31-year non-smoker man, working in plastic making industry for 12 years presented with cough and streaking hemoptysis for 2 days. Computed tomography (CT) of chest showed patchy ground glass opacities with interlobular septal thickening in bilatera

Externí odkaz: https://doaj.org/article/42a57449e067491d8caf94a074a029a0

Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process

Autor: Joshua J Solomon, Vibeke Strand, Chester V. Oddis, Leticia Kawano-Dourado, Tracy J. Doyle, Jeffrey A. Sparks, Kevin K. Brown, Susanna Proudman, Athol U. Wells, Donald P. Tashkin, Dorcas E. Beaton, Dinesh Khanna, Whitney Townsend, Lara J Maxwell, Shaney L Barratt, James R. Seibold, Paul F. Dellaripa, Robert Vassallo, David Roofeh, Eric L. Matteson, Thomas Leonard, Robin Christensen

Publikováno v: Semin Arthritis Rheum
Roofeh, D, Barratt, S L, Wells, A U, Kawano-Dourado, L, Tashkin, D, Strand, V, Seibold, J, Proudman, S, Brown, K K, Dellaripa, P F, Doyle, T, Leonard, T, Matteson, E L, Oddis, C V, Solomon, J J, Sparks, J A, Vassallo, R, Maxwell, L, Beaton, D, Christensen, R, Townsend, W & Khanna, D 2021, ' Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease : A systematic review using the OMERACT filter 2.1 process ', Seminars in Arthritis and Rheumatism, vol. 51, no. 6, pp. 1331-1341 . https://doi.org/10.1016/j.semarthrit.2021.08.001

Objective The Outcome Measures in Rheumatology (OMERACT) is a research organization focused on improving health care outcomes for patients with autoimmune and musculoskeletal diseases. The Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2143bc5443447d75f72bb9600b24f2a8
https://doi.org/10.1016/j.semarthrit.2021.08.001

Interferon-β-Induced Pulmonary Arterial Hypertension: Approach to Diagnosis and Clinical Monitoring

Autor: Raza, Farhan, Kozitza, Callyn, Chybowski, Amy, Goss, Kara N, Berei, Theodore, Runo, James, Eldridge, Marlowe, Chesler, Naomi

Publikováno v: JACC. Case reports, vol 3, iss 7

A 48-year-old woman who had been receiving long-term interferon-β for 8 years for multiple sclerosis developed drug-induced World Health Organization group I pulmonary arterial hypertension. Triple therapy for pulmonary arterialhypertension and susp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::3ea0c3d347701c41107731952460f909
https://escholarship.org/uc/item/15z3x372

Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases

Autor: Hildebrandt, Julia, Rahn, Anja, Kessler, Anja, Speth, Fabian, Fischer, Dagmar-Christiane, Ballmann, Manfred

Publikováno v: Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-5 (2021)

Background In adults with rheumatic diseases pulmonary complications are relevant contributors to morbidity and mortality. In these patients diffusion capacity for CO (DLCO) is an established method to detect early pulmonary impairment. Pilot studies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4385fbb33f12b152ad3545d59dd9f407
http://europepmc.org/articles/PMC7937245